Denileukine Diftitox for Relapsed ALCL
NCT00801918
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Lack of funding
Conditions
Anaplastic Large-Cell Lymphoma
Interventions
DRUG:
Denileukin Diftitox
DRUG:
Denileukin diftitox, ifosfamide, cyclophosphamide, etoposide
Sponsor
Columbia University